CardioFlow Medtech

CardioFlow Medtech is a leading medical device company specializing in the development and commercialization of transcatheter heart valve therapies. A subsidiary of MicroPort Scientific Corporation, the company focuses on treating structural heart diseases, particularly valvular heart disease. Its flagship products include the VitaFlow and VitaFlow Liberty Transcatheter Aortic Valve Implantation (TAVI) systems, which are designed for minimally invasive treatment of aortic stenosis. CardioFlow is also expanding its pipeline to include transcatheter mitral and tricuspid valve replacement and repair solutions. The company is headquartered in Shanghai and is listed on the Hong Kong Stock Exchange, serving patients across China and international markets.